Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis
- PMID: 24291192
- DOI: 10.1016/j.biochi.2013.11.011
Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis
Abstract
Peroxisome proliferator-activated receptor-α (PPARα) modulates the activities of all three interlinked hepatic fatty acid oxidation systems, namely mitochondrial and peroxisomal β-oxidation and microsomal ω-oxidation pathways. Hyperactivation of PPARα, by both exogenous and endogenous activators up-regulates hepatic fatty acid oxidation resulting in excess energy burning in liver contributing to the development of liver cancer in rodents. Sustained PPARα signaling disproportionately increases H2O2-generating fatty acid metabolizing enzymes as compared to H2O2-degrading enzymes in liver leading to enhanced generation of DNA damaging reactive oxygen species, progressive endoplasmic reticulum stress and inflammation. These alterations also contribute to increased liver cell proliferation with changes in apoptosis. Thus, reactive oxygen species, oxidative stress and hepatocellular proliferation are likely the main contributing factors in the pathogenesis of hepatocarcinogenesis, mediated by sustained PPARα activation-related energy burning in liver. Furthermore, the transcriptional co-activator Med1, a key subunit of the Mediator complex, is essential for PPARα signaling in that both PPARα-null and Med1-null hepatocytes are unresponsive to PPARα activators and fail to give rise to liver tumors when chronically exposed to PPARα activators.
Keywords: Energy combustion; Fatty acid oxidation; Liver tumors; Med1; Oxidative stress; PPARα.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis.Subcell Biochem. 2013;69:77-99. doi: 10.1007/978-94-007-6889-5_5. Subcell Biochem. 2013. PMID: 23821144 Review.
-
Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis.Gene Expr. 2014;16(2):63-75. doi: 10.3727/105221614X13919976902219. Gene Expr. 2014. PMID: 24801167 Free PMC article. Review.
-
Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.Mutat Res. 2000 Mar 17;448(2):159-77. doi: 10.1016/s0027-5107(99)00234-1. Mutat Res. 2000. PMID: 10725470 Review.
-
PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.Nucl Recept Signal. 2010 Apr 16;8:e002. doi: 10.1621/nrs.08002. Nucl Recept Signal. 2010. PMID: 20414453 Free PMC article. Review.
-
Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.Cancer Res. 2004 Jun 1;64(11):3849-54. doi: 10.1158/0008-5472.CAN-04-0322. Cancer Res. 2004. PMID: 15172993
Cited by
-
Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives.Mol Cancer. 2024 Jan 24;23(1):22. doi: 10.1186/s12943-024-01934-y. Mol Cancer. 2024. PMID: 38262996 Free PMC article. Review.
-
Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features.Open Life Sci. 2023 Sep 8;18(1):20220696. doi: 10.1515/biol-2022-0696. eCollection 2023. Open Life Sci. 2023. PMID: 37724116 Free PMC article.
-
Effects of peroxisome proliferator activated receptor-α agonist on growth performance, blood profiles, gene expression related to liver fat metabolism in broilers fed diets containing corn naturally contaminated with mycotoxins.Front Vet Sci. 2023 Jan 4;9:1103185. doi: 10.3389/fvets.2022.1103185. eCollection 2022. Front Vet Sci. 2023. PMID: 36686165 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489. Int J Mol Sci. 2022. PMID: 36555127 Free PMC article. Review.
-
Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology.Signal Transduct Target Ther. 2022 Nov 19;7(1):379. doi: 10.1038/s41392-022-01243-0. Signal Transduct Target Ther. 2022. PMID: 36402753 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
